Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
- PMID: 2684645
- PMCID: PMC402051
- DOI: 10.1002/j.1460-2075.1989.tb08543.x
Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
Abstract
Human malignant melanomas, unlike normal melanocytes, can proliferate in the absence of exogenous basic fibroblast growth factor (bFGF). Exposure of primary melanomas in the vertical growth phase and metastatic melanomas to antisense oligodeoxynucleotides targeted against three different sites of human bFGF mRNA inhibited cell proliferation and colony formation in soft-agar. In contrast, exposure of human bFGF sense or antisense oligonucleotides complementary to human beta-nerve growth factor or insulin-like growth factor I mRNA had no such effects. These experiments indicate that activation of the bFGF gene may play an important role in the progression from melanocytic precursor lesions to malignant melanoma.
Similar articles
-
Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation.Oncogene. 1992 Nov;7(11):2303-13. Oncogene. 1992. PMID: 1437152
-
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.J Immunol. 1993 Sep 1;151(5):2667-75. J Immunol. 1993. PMID: 8360485
-
Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth.Nat Med. 1997 Aug;3(8):887-93. doi: 10.1038/nm0897-887. Nat Med. 1997. PMID: 9256280
-
Growth factors and tyrosine protein kinases in normal and malignant melanocytes.Cancer Metastasis Rev. 1991 Jun;10(2):129-40. doi: 10.1007/BF00049410. Cancer Metastasis Rev. 1991. PMID: 1873853 Review.
-
Growth control of melanoma cells and melanocytes by cytokines.Recent Results Cancer Res. 1995;139:169-82. doi: 10.1007/978-3-642-78771-3_12. Recent Results Cancer Res. 1995. PMID: 7597288 Review.
Cited by
-
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors.Pigment Cell Melanoma Res. 2015 Jul;28(4):417-30. doi: 10.1111/pcmr.12376. Epub 2015 May 6. Pigment Cell Melanoma Res. 2015. PMID: 25854919 Free PMC article.
-
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.J Clin Invest. 1994 Nov;94(5):1736-46. doi: 10.1172/JCI117521. J Clin Invest. 1994. PMID: 7525646 Free PMC article.
-
Modulation of multidrug resistance with antisense oligodeoxynucleotide to mdr1 mRNA.Ann Surg Oncol. 1996 Jan;3(1):80-5. doi: 10.1007/BF02409056. Ann Surg Oncol. 1996. PMID: 8770307
-
A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.J Exp Med. 1993 Apr 1;177(4):1135-43. doi: 10.1084/jem.177.4.1135. J Exp Med. 1993. PMID: 8096237 Free PMC article.
-
Angiogenic capacity and lung-colonizing potential in vivo is increased in weakly metastatic B16F1 cells and decreased in highly metastatic BL6 cells by phorbol esters.Clin Exp Metastasis. 1998 Jul;16(5):399-405. doi: 10.1023/a:1006598306743. Clin Exp Metastasis. 1998. PMID: 10091935
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical